Le Lézard
Classified in: Science and technology, Business
Subjects: FOR, CFG

Powered by and for the people - Engineers in Canada and India will work together to further energy-efficient technology and create local jobs


GUJARAT, India, Feb. 19, 2017 /CNW/ - An issue faced by many countries is the need for clean, efficient sources of energy to power their homes, schools, hospitals and businesses. With reliable energy sources comes an improved, more consistent quality of life.

That's why engineers in Canada and India are working together under a new research partnership agreement between Toronto-based energy consulting company Kinectrics and the Gujarat Forensic Sciences University (GFSU). The partnership involves a new state-of-the-art laboratory to test and develop conductors that can transfer significantly more electricity to highly populated areas or to industrial hubs than ever before and at lower cost.

Today the Honourable Kirsty Duncan, Minister of Science and Minister of Sport and Persons with Disabilities, participated in a stone-laying ceremony for the new laboratory. 

Researchers working in this innovative facility will develop practical and cost-effective high-capacity transmission conductors that will improve the long-term quality and reliability of energy sources for the people of India.

Kinectrics and GSFU are each investing $1.75 million. The partnership will create research collaborations between Canadian and Indian scientists as well as training opportunities for Indian students who will be equipped with the skills they need for high-quality jobs in the growing energy sector.

Quotes

"I applaud the partnership between Kinectrics and GFSU and look forward to their efficient-energy technologies that will be the source of new opportunities for learning, training and local jobs. It's technologies like these that have the greatest potential to impact our daily lives and improve our quality of life."
? The Honourable Kirsty Duncan, Minister of Science and Minister of Sport and Persons with Disabilities

"This will be the first laboratory in the world built specifically for testing high-temperature low-sag [HTLS] conductors. Local testing will support a cost-effective approval process for HTLS conductors to service the growing demand for electricity in India, assuring long-term quality and reliability of power delivery to the public."
? David Harris, Chief Executive Officer, Kinectrics

Quick facts

Follow Minister Duncan on social media.

Twitter: @ScienceMin
Instagram: sciencemin

 

SOURCE Innovation, Science and Economic Development Canada


These press releases may also interest you

at 07:15
Draganfly Inc. ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer is pleased to announce a strategic collaboration with ParaZero Technologies Ltd., a pioneer in drone safety systems aimed at...

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:07
MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the Document Solutions v7.1 release. This release introduces features and enhancements to MESCIUS's server-side document APIs, JavaScript...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...

at 07:05
Mind Medicine (MindMed) Inc. , (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study...



News published on and distributed by: